These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3554759)

  • 21. Genetics of type 1 diabetes.
    Kelly MA; Mijovic CH; Barnett AH
    Best Pract Res Clin Endocrinol Metab; 2001 Sep; 15(3):279-91. PubMed ID: 11554771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of immunologic factors in the pathogenesis of encephalomyocarditis virus induced diabetes in mice.
    Dafoe DC; Moore CL; Plotkin SA; Naji A; Barker CF
    Behring Inst Mitt; 1984 Jul; (75):17-25. PubMed ID: 6091611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage.
    Waldron-Lynch F; Herold KC
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):303-17, viii. PubMed ID: 19328413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is prevention of diabetes mellitus possible?].
    Lehmann R; Spinas GA
    Ther Umsch; 1994 Oct; 51(10):693-700. PubMed ID: 7839327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulation for the prevention of SPIDDM and LADA.
    Pozzilli P; Guglielmi C
    Ann N Y Acad Sci; 2006 Oct; 1079():90-8. PubMed ID: 17130536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune intervention in type I diabetes mellitus--current clinical and experimental approaches.
    Kolb H
    Exp Clin Endocrinol; 1994; 102(4):269-72. PubMed ID: 7813597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candidate genes and late-onset type 2 diabetes mellitus. Susceptibility genes or common polymorphisms?
    Hansen L
    Dan Med Bull; 2003 Nov; 50(4):320-46. PubMed ID: 14694850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of Type 1 diabetes mellitus.
    Friday RP; Trucco M; Pietropaolo M
    Diabetes Nutr Metab; 1999 Feb; 12(1):3-26. PubMed ID: 10517302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopathogenesis and immunotherapy of type 1 diabetes.
    Wilson K; Eisenbarth GS
    Annu Rev Med; 1990; 41():497-508. PubMed ID: 2184747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunotherapy of insulin-dependent diabetes mellitus].
    Satoh J; Seino H; Shintani S; Toyota T
    Nihon Rinsho; 1991 Feb; 49 Suppl():519-24. PubMed ID: 2033845
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypothesis for the pathogenesis of type 1A diabetes.
    Jasinski JM; Eisenbarth GS
    Drugs Today (Barc); 2005 Feb; 41(2):141-9. PubMed ID: 15821785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunointervention in type 1 diabetes mellitus].
    Vialettes B
    Diabete Metab; 1992; 18(1):3-10; discussion 11-3. PubMed ID: 1563533
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunosuppressive therapy in newly diagnosed diabetic children (comparison between two different strategies).
    Pocecco M; Marinoni S; Tonini G; Tedesco F
    J Endocrinol Invest; 1989; 12(8 Suppl 3):143-4. PubMed ID: 2809092
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathophysiology of immune-mediated (type 1) diabetes mellitus: potential for immunotherapy.
    Abel M; Krokowski M
    BioDrugs; 2001; 15(5):291-301. PubMed ID: 11437693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in non-specific and semi-specific immunosuppression in type I diabetes.
    Leslie RD; Carotenuto P; Pozzilli P
    Diabetes Metab Rev; 1993 Dec; 9(4):257-67. PubMed ID: 7924823
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunotherapies currently in development for the treatment of type 1 diabetes.
    Davis IC; Randell J; Davis SN
    Expert Opin Investig Drugs; 2015; 24(10):1331-41. PubMed ID: 26364507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Has immunotherapy a place in insulin-dependent diabetes of children?].
    Lestradet H
    Bull Acad Natl Med; 1988 Feb; 172(2):143-9. PubMed ID: 3042098
    [No Abstract]   [Full Text] [Related]  

  • 39. [Can insulin-dependent diabetes be cured or prevented?].
    Bach JF
    Rev Prat; 1992 Jan; 42(2):199-200. PubMed ID: 1566001
    [No Abstract]   [Full Text] [Related]  

  • 40. [Perspectives of immunosuppressive treatment for the prevention of diabetes mellitus type I].
    Estopiñán García V; Fortea Gimeno L
    An Med Interna; 1992 Oct; 9(10):471-2. PubMed ID: 1420756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.